NCT01357876View on ClinicalTrials.gov

Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

October 1, 2010

Primary Completion Date

July 7, 2011

Study Completion Date

July 7, 2011

Conditions

Diabetes Mellitus, Type 2

Interventions

OTHER

Metformin

withdrawral

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01357876 - Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics | Biotech Hunter | Biotech Hunter